1. Home
  2. MIRM vs PSMT Comparison

MIRM vs PSMT Comparison

Compare MIRM & PSMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIRM
  • PSMT
  • Stock Information
  • Founded
  • MIRM 2018
  • PSMT 1994
  • Country
  • MIRM United States
  • PSMT United States
  • Employees
  • MIRM N/A
  • PSMT N/A
  • Industry
  • MIRM Biotechnology: Pharmaceutical Preparations
  • PSMT Department/Specialty Retail Stores
  • Sector
  • MIRM Health Care
  • PSMT Consumer Discretionary
  • Exchange
  • MIRM Nasdaq
  • PSMT Nasdaq
  • Market Cap
  • MIRM 3.8B
  • PSMT 3.6B
  • IPO Year
  • MIRM 2019
  • PSMT 1997
  • Fundamental
  • Price
  • MIRM $72.65
  • PSMT $114.94
  • Analyst Decision
  • MIRM Strong Buy
  • PSMT
  • Analyst Count
  • MIRM 11
  • PSMT 0
  • Target Price
  • MIRM $79.00
  • PSMT N/A
  • AVG Volume (30 Days)
  • MIRM 560.3K
  • PSMT 194.2K
  • Earning Date
  • MIRM 11-04-2025
  • PSMT 10-30-2025
  • Dividend Yield
  • MIRM N/A
  • PSMT 1.10%
  • EPS Growth
  • MIRM N/A
  • PSMT 5.47
  • EPS
  • MIRM N/A
  • PSMT 4.82
  • Revenue
  • MIRM $429,161,000.00
  • PSMT $5,270,094,000.00
  • Revenue This Year
  • MIRM $53.14
  • PSMT $9.55
  • Revenue Next Year
  • MIRM $19.83
  • PSMT $8.86
  • P/E Ratio
  • MIRM N/A
  • PSMT $23.85
  • Revenue Growth
  • MIRM 62.33
  • PSMT 7.25
  • 52 Week Low
  • MIRM $36.88
  • PSMT $81.25
  • 52 Week High
  • MIRM $78.55
  • PSMT $125.48
  • Technical
  • Relative Strength Index (RSI)
  • MIRM 52.77
  • PSMT 37.40
  • Support Level
  • MIRM $68.34
  • PSMT $119.33
  • Resistance Level
  • MIRM $71.96
  • PSMT $124.01
  • Average True Range (ATR)
  • MIRM 2.53
  • PSMT 3.01
  • MACD
  • MIRM -0.13
  • PSMT -0.84
  • Stochastic Oscillator
  • MIRM 56.54
  • PSMT 23.75

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

About PSMT PriceSmart Inc.

Pricesmart Inc is principally engaged in operating U.S.-style membership shopping warehouse clubs that offer consumer goods at low prices. The company is headquartered in San Diego, California, United States, and operates stores in the Caribbean, Costa Rica, Panama, and other regions. The company's revenue consists of net warehouse club sales from merchandise sales, membership income from annual membership fees, export sales, and other income. Its operations consist of four reportable segments; Central America, the Caribbean, Colombia, and the United States. A majority of the company's revenue is derived from Central America.

Share on Social Networks: